Sensitivity Analysis of Outcomes after 10 years of PrEP Implementation.

*Parameters that contribute 5% or more of the variance in the model outcome are shown (SRRC2≥0.05). The reported coefficients were significant with a p-value≤0.05.§Of the total variance in the predicted outcome explained by the regression model. The respective R2 values were: 0.91 (cumulative infections prevented); 0.85 (overall prevalence of resistance); 0.89 (prevalence of transmitted resistance); 0.85 (prevalence of acquired resistance); and 0.89 (resistant cumulative infections).†Proportion of cases with drug-resistant infection in the infected population.